Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$328,641
+$70,046 QoQ
Shares Held
1,306
+9.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#3,547
of 4,153 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rialto Wealth Management, LLC holds $3,535,649 across 12 Drug Manufacturers - General names. ABBV ranks #4 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
3,295 | $1,193,185 | |
| 2 | JNJ |
Johnson & Johnson
|
2,996 | $760,894 | |
| 3 | MRK |
Merck & Co., Inc.
|
5,295 | $680,407 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
1,306 | $328,641 | |
| 5 | LLY |
ELI LILLY & Co
|
230 | $275,868 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,091 | $137,836 | |
| 7 | AZN |
Astrazeneca PLC
|
251 | $47,594 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
684 | $39,412 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $328,641 | 1,306 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $258,595 | 1,189 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $257,508 | 1,127 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $263,724 | 1,139 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $207,708 | 1,119 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $231,310 | 1,104 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $193,159 | 1,087 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||